Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)

Papp, Kim; Reich, Kristian; Leonardi, Craig L.; Kircik, Leon; Chimenti, Sergio; Langley, Richard G.B.; Hu, ChiaChi; Stevens, Randall M.; Day, Robert M.; Gordon, Kenneth B.; Korman, Neil J.; Griffiths, Christopher E.M.

期刊名称Journal of the American Academy of Dermatology
作者Papp, Kim; Reich, Kristian; Leonardi, Craig L.; Kircik, Leon; Chimenti, Sergio; Langley, Richard G.B.; Hu, ChiaChi; Stevens, Randall M.; Day, Robert M.; Gordon, Kenneth B.; Korman, Neil J.; Griffiths, Christopher E.M.
卷第73卷
期第1期
印刷ISSN0190-9622
文件大小1737.40KB
发表时间2015-07
DOI10.1016/j.jaad.2015.03.049
页码37-49

发现好书期刊，享受阅读乐趣

Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)